Back to User profile » Dr Jingjing Zhao
Papers published by Dr Jingjing Zhao:
Apatinib Combined with Irinotecan in the Treatment of Advanced Small-Cell Esophageal Carcinoma: A Case Report
Guo L, Zou X, Gu Y, Yi L, Zhao J, Wu G
OncoTargets and Therapy 2021, 14:1989-1995
Published Date: 18 March 2021
IL-37 induces anti-tumor immunity by indirectly promoting dendritic cell recruitment and activation in hepatocellular carcinoma
Liu Y, Zhao JJ, Zhou ZQ, Pan QZ, Zhu Q, Tang Y, Xia JC, Weng DS
Cancer Management and Research 2019, 11:6691-6702
Published Date: 18 July 2019
Orchestration of immune checkpoints in tumor immune contexture and their prognostic significance in esophageal squamous cell carcinoma
Zhao JJ, Zhou ZQ, Wang P, Chen CL, Liu Y, Pan QZ, Zhu Q, Tang Y, Weng DS, Xia JC
Cancer Management and Research 2018, 10:6457-6468
Published Date: 28 November 2018
Treatment-related adverse effects with pazopanib, sorafenib and sunitinib in patients with advanced soft tissue sarcoma: a pooled analysis
Que Y, Liang Y, Zhao JJ, Ding Y, Peng RQ, Guan YX, Zhang X
Cancer Management and Research 2018, 10:2141-2150
Published Date: 19 July 2018
A favorable outcome of advanced dermatofibrosarcoma protuberans under treatment with sunitinib after imatinib failure
Xiao W, Que Y, Peng RQ, Ding Y, Zhao JJ, Wen XZ, Weng DS, Zhang XS, Guan YX, Zhang X
OncoTargets and Therapy 2018, 11:2439-2443
Published Date: 1 May 2018